{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:21:51Z","timestamp":1794590511253,"version":"4.9.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04387-2","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:38:06Z","timestamp":1748468286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical trial landscape of gene therapy for retinal degenerative diseases: an analysis based on the Trialtrove database"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4418-4844","authenticated-orcid":false,"given":"Shizhou","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuyun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanghao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"7","key":"4387_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/iovs.64.7.39","volume":"64","author":"S Drag","year":"2023","unstructured":"Drag S, Dotiwala F, Upadhyay AK. Gene therapy for retinal degenerative diseases: progress, challenges, and future directions. Invest Ophthalmol Vis Sci. 2023;64(7):39.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4387_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109596","volume":"234","author":"J Lu","year":"2023","unstructured":"Lu J, Zheng KQ, Bertrand RE, Quinlan J, Ferdous S, Srinivasan T, Oh S, Wang K, Chen R. Gene augmentation therapy to rescue degenerative photoreceptors in a Cwc27 mutant mouse model. Exp Eye Res. 2023;234: 109596.","journal-title":"Exp Eye Res"},{"issue":"5","key":"4387_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40291-024-00722-0","volume":"28","author":"ME McClements","year":"2024","unstructured":"McClements ME, Elsayed M, Major L, de la Camara CM, MacLaren RE. Gene therapies in clinical development to treat retinal disorders. Mol Diagn Ther. 2024;28(5):575\u201391.","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"4387_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13045-023-01457-x","volume":"16","author":"D Wu","year":"2023","unstructured":"Wu D, Hu L, Wang X, Yu Y, Jia SP, Huang HY, Li ZW, Ma JF, Zhu HB, Tang Y, et al. Clinical development of mRNA therapies against solid tumors. J Hematol Oncol. 2023;16(1):75.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"4387_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104223","volume":"29","author":"X Zhong","year":"2024","unstructured":"Zhong X, Lin S, Deng M, Guan L. The global status of bioequivalence trials: a comprehensive clinical trial landscape analysis based on the Trialtrove database. Drug Discov Today. 2024;29(12): 104223.","journal-title":"Drug Discov Today"},{"issue":"1","key":"4387_CR6","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1038\/s41467-024-46945-x","volume":"15","author":"AV Kammula","year":"2024","unstructured":"Kammula AV, Schaffer AA, Rajagopal PS, Kurzrock R, Ruppin E. Outcome differences by sex in oncology clinical trials. Nat Commun. 2024;15(1):2608.","journal-title":"Nat Commun"},{"issue":"1","key":"4387_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1146\/annurev-virology-092818-015530","volume":"6","author":"AM Keeler","year":"2019","unstructured":"Keeler AM, Flotte TR. Recombinant adeno-associated virus gene therapy in light of luxturna (and Zolgensma and Glybera): where are we, and how did we get here? Annu Rev Virol. 2019;6(1):601\u201321.","journal-title":"Annu Rev Virol"},{"issue":"8","key":"4387_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.molmed.2018.06.006","volume":"24","author":"I Trapani","year":"2018","unstructured":"Trapani I, Auricchio A. Seeing the light after 25 years of retinal gene therapy. Trends Mol Med. 2018;24(8):669\u201381.","journal-title":"Trends Mol Med"},{"issue":"5","key":"4387_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/14712598.2020.1693541","volume":"20","author":"MG Moleirinho","year":"2020","unstructured":"Moleirinho MG, Silva RJS, Alves PM, Carrondo MJT, Peixoto C. Current challenges in biotherapeutic particles manufacturing. Expert Opin Biol Ther. 2020;20(5):451\u201365.","journal-title":"Expert Opin Biol Ther"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04387-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04387-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04387-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:38:07Z","timestamp":1748468287000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04387-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4387"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04387-2","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate is not applicable for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication from participants is not applicable for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have not use AI-generated work in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI-generated"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"257"}}